摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-3-(2-chlorophenyl)-1-[6-(cyclohexylamino)pyridin-3-yl]prop-2-en-1-one | 1220889-42-8

中文名称
——
中文别名
——
英文名称
(E)-3-(2-chlorophenyl)-1-[6-(cyclohexylamino)pyridin-3-yl]prop-2-en-1-one
英文别名
——
(E)-3-(2-chlorophenyl)-1-[6-(cyclohexylamino)pyridin-3-yl]prop-2-en-1-one化学式
CAS
1220889-42-8
化学式
C20H21ClN2O
mdl
——
分子量
340.853
InChiKey
FZMLZJKHNRBRNT-ZRDIBKRKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    42
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    (E)-3-(2-chlorophenyl)-1-(6-fluoropyridin-3-yl)prop-2-en-1-one 、 环己胺potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 (E)-3-(2-chlorophenyl)-1-[6-(cyclohexylamino)pyridin-3-yl]prop-2-en-1-one
    参考文献:
    名称:
    Exploration of a new series of PAR1 antagonists
    摘要:
    Two series of new PAR1 antagonists have been identified. The first incorporates a cinnamoylpiperidine motif and the second a cinnamoylpyridine pattern. The synthesis, biological activity and structure-activity relationship of these compounds are presented. In each series, one analog showed potent in vivo anti-thrombotic activity in a rat AV shunt model, with up to 53% inhibition at 1.25 mpk iv for compound 30. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.01.050
点击查看最新优质反应信息

文献信息

  • Exploration of a new series of PAR1 antagonists
    作者:Bruno Planty、Chantal Pujol、Marie Lamothe、Catherine Maraval、Clemens Horn、Bruno Le Grand、Michel Perez
    DOI:10.1016/j.bmcl.2010.01.050
    日期:2010.3
    Two series of new PAR1 antagonists have been identified. The first incorporates a cinnamoylpiperidine motif and the second a cinnamoylpyridine pattern. The synthesis, biological activity and structure-activity relationship of these compounds are presented. In each series, one analog showed potent in vivo anti-thrombotic activity in a rat AV shunt model, with up to 53% inhibition at 1.25 mpk iv for compound 30. (C) 2010 Elsevier Ltd. All rights reserved.
查看更多